EviCure
Latest round
- Seed
Last raised
- May 2026
Total raised
- $0.1M
Investors
- 1
About EviCure
Founded in 2023 in Ness Ziona, Israel, EviCure Ltd. focuses on anti-cancer therapies, particularly for refractory non-small cell lung cancer (NSCLC). EviCure is not known to have any subsidiaries, nor was it formed through a merger.EviCure specializes in anti-cancer precision therapies, leveraging innovative technologies centered around extracellular vesicles (EVs). Their flagship product, PL-Ex1, is an EV-based treatment specifically designed for refractory non-small cell lung cancer (NSCLC), addressing critical unmet medical needs in oncology. The company focuses on the discovery and application of the unique molecular cargo found within stem cells and EV subpopulations, which exhibit selective therapeutic effects and superior anti-tumor activity. These products are intended for healthcare providers and clinical research institutions involved in cancer treatment, primarily targeting markets in Europe, North America, and Asia, where the prevalence of solid cancers is rising.EviCure's revenue structure is built on a business-to-business (B2B) model, targeting partnerships with hospitals, research institutions, and pharmaceutical companies interested in advanced cancer treatments. The company generates income through the sale of its trademarked product, PL-Ex1, alongside potential future offerings derived from their extensive research on EV libraries and AI technology. Each transaction typically involves agreements for the distribution of their products, potentially supplemented by collaborative research initiatives aimed at further developing their therapeutic solutions. The pricing structure for PL-Ex1 and subsequent products is tailored to accommodate institutional clients, reflecting the specialized nature of their offerings and the complexity inherent in cancer treatment solutions.EviCure aims to enhance its product lineup with new therapeutics targeting solid tumors, with plans for upcoming releases in the next two years.
Who invested in EviCure
1 investor across 4 rounds
See all investors in EviCure
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EviCure
Who invested in EviCure?
EviCure has 1 investor on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EviCure raised?
EviCure has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did EviCure last raise money?
EviCure's most recent round on record is a Seed, in May 2026.
What does EviCure do?
Founded in 2023 in Ness Ziona, Israel, EviCure Ltd.
Where is EviCure headquartered?
EviCure is headquartered in Ness Ziona, Israel.
Which VCs invest in companies like EviCure?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back medical devices & equipment companies at EviCure's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like EviCure? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.